Innodata vs. Workiva: Which Tech Stock Is a Better Buy in 2026?

Innodata posted fiscal 2025 revenue of nearly $252 million, up 48% year over year, with about $32 million in net income, while Workiva grew revenue nearly 20% to $884 million and narrowed its net loss to about $26 million. The article favors Innodata for long-term AI-driven upside, but highlights major risks from 58% customer concentration, project-based contracts, and ongoing legal exposure in the Philippines, versus Workiva’s slower growth but more predictable recurring revenue base. Valuation is far richer for Innodata at 88.5x forward P/E and 12.4x sales versus Workiva at 16.3x forward P/E and 3.0x sales.

Analysis

The market is likely underpricing the asymmetry between the two names: INOD is a highly leveraged call option on AI data-prep spend, while WK is a slower compounding software asset with less operating leverage but much lower headline multiples. The key second-order issue is that if frontier-model builders internalize more of the labeling / cleaning workflow, INOD’s growth can decelerate very quickly; conversely, if AI training remains a mix of in-house plus outsourced pipelines, INOD can keep scaling for years and absorb valuation pain through revenue compounding. That makes the name more dependent on customer architecture decisions than on simple AI demand growth.

WK’s hidden strength is not just recurring revenue, but governance inertia: once finance, audit, sustainability, and controls workflows are embedded, switching costs tend to rise nonlinearly as organizations scale and face more scrutiny. The risk is that its AI feature set becomes table stakes rather than a differentiator, which would cap pricing power and keep margin expansion gradual. Still, the current setup looks more like a durable cash-generation story than a balance-sheet risk story, and the market may be over-focusing on reported leverage while underappreciating the stickiness of compliance workflows.

The contrarian view is that the consensus is treating INOD’s customer concentration as a static risk when it is actually the core watch item for whether the bull case is investable. If the company continues to diversify away from the dominant client, the multiple can stay elevated even if growth normalizes; if diversification stalls for two quarters, the stock likely rerates sharply because the market will start discounting order-book fragility. On WK, the bigger catalyst is not top-line acceleration but a sustained move toward break-even free-cash-flow conversion without incremental SBC dilution; absent that, the equity can remain range-bound despite strong enterprise penetration.

Key Decisions for Investors

• Long INOD only on confirmation of customer diversification: add on a 2-quarter streak where non-anchor revenue grows faster than total revenue; upside is multiple preservation, but if concentration remains >50%, expect a sharp de-rating.
• Buy WK on pullbacks as a quality compounder: 12-24 month horizon, targeting recurring-revenue visibility and potential operating leverage; risk/reward is better than the market implies if margin expansion continues.
• Pair trade: long WK / short ORCL over 6-12 months if the thesis is governance/workflow stickiness versus broad-suite competition; WK has cleaner product focus and less integration drag.
• Avoid chasing INOD after large gap-ups; use call spreads instead of common stock for 3-6 month exposure to AI spend optionality, because valuation compression is the main risk even if fundamentals stay strong.
• Set a stop-monitor on INOD if quarterly customer concentration does not improve; a failed diversification narrative is the fastest path to a 30-50% downside re-rating.